Conferences Agomab Therapeutics is attending in 2026

Agomab Therapeutics is listed at 2 conferences on Tnuki's calendar in 2026: BioTechX Europe 2026 (on the program) and BIO-Europe 2026 (on the program). Agomab Therapeutics is a clinical-stage biotechnology company developing medicines targeting transforming growth factor beta pathways for fibrotic diseases. As of Sep 29, 2026.

ConferenceDetailsInvolvementTnuki guide
BioTechX Europe 2026European pharma data & informatics leadersOfficial site
Basel, Switzerland ~3k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 talk
Attending
  • Head Corporate Strategic Initiatives & AI
Attendee mix: Mostly industry; R&D IT, data science, discovery informatics and clinical data leaders in pharma and biotech
Open the guide Search and filter attendees
BIO-Europe 2026European biotech partnering & BDOfficial site
Cologne, Germany ~5.8k attendees On the programNo booth or sponsorship in the organizer’s published lists
Program 1 panel discussion
Attending
  • CBO
Attendee mix: Almost entirely industry; European biotech and pharma BD executives, licensing teams and investors
Open the guide Search and filter attendees

We hold published exhibitor, sponsor, program or attendee lists for 29 of the 90 conferences on our calendar, so this page shows Agomab Therapeutics’s involvement at those 29 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.

Instantly find decision makers at Agomab Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

See what Tnuki can do

Explore our deep integration of account and market intelligence, in one easy-to-use chat.

Or talk to a human →